In support of this, an antimalarial drug, artesunate, downregulated IFN induced STAT1 phosphorylation in SLE PBMC's in vitro, which reduced production of macrophage migration inhibitory factor (MIF), a key regulator of both atherosclerosis and SLE [69]. The gene discussed is STAT1; the disease is systemic lupus erythematosus.